| Specialty Retail Industry | Consumer Discretionary Sector | Kim Eun-Seok CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
DAE HWA Pharmaceutical Co., Ltd., established in 1984, is a prominent pharmaceutical company based in Seoul, South Korea. With a focus on innovation and quality, the company specializes in the production and supply of a wide array of pharmaceutical products catering to various therapeutic areas. DAE HWA Pharmaceutical is dedicated to improving healthcare outcomes for patients through its extensive portfolio of medications and advanced drug delivery systems. The company’s commitment to R&D and global health has enabled it to expand its market presence to approximately 22 countries across Asia, South America, the Middle East, and Africa. Through persistent efforts in innovation and expansion, DAE HWA strives to meet the diverse healthcare needs of communities worldwide.
DAE HWA Pharmaceutical Co., Ltd. offers a comprehensive range of pharmaceutical products and services, including:
These offerings underline DAE HWA Pharmaceutical’s dedication to advancing healthcare across multiple fronts, leveraging cutting-edge science and technology to deliver effective solutions.